KD-027

• Description :

  KD-027 (SLx-2101) is a Phosphodiesterase 5 (PDE5) inhibitor. KD-027 can be used for endothelial dysfunction, and hypertension research[1].

• Product Name Alternative :

  SLx-2101

• UNSPSC :

  12352005

• Target :

  Phosphodiesterase (PDE)

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Cardiovascular Disease

• Smiles :

  O=C(N(C(CN(S(=O)(C1=CC=C(OCC)C(C(NN2C3=C(C)N=C2CCC)=NC3=O)=C1)=O)C)=O)C)CN(C)C

• Molecular Formula :

  C25H35N7O6S

• Molecular Weight :

  561.65

• References & Citations :

  [1]Melchiode Z, et al. Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments. Expert Opin Investig Drugs. 2023 Jul-Dec;32 (7) :635-642.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  PDE5

• CAS Number :

  [906421-01-0]